MENU
+Compare
ACRS
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$2.10
Change
+$0.03 (+1.45%)
Capitalization
227.5M

ACRS Aclaris Therapeutics Forecast, Technical & Fundamental Analysis

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States... Show more

ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACRS with price predictions
Sep 04, 2025

Aroon Indicator for ACRS shows an upward move is likely

ACRS's Aroon Indicator triggered a bullish signal on September 04, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 204 similar instances where the Aroon Indicator showed a similar pattern. In of the 204 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on ACRS as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACRS just turned positive on August 12, 2025. Looking at past instances where ACRS's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACRS advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACRS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACRS broke above its upper Bollinger Band on September 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.727) is normal, around the industry mean (19.994). P/E Ratio (0.000) is within average values for comparable stocks, (51.700). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (12.870) is also within normal values, averaging (325.279).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACRS is expected to report earnings to -12 cents per share on November 05

Aclaris Therapeutics ACRS Stock Earnings Reports
Q3'25
Est.
$-0.13
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.72
Q3'24
Missed
by $0.10
The last earnings report on August 07 showed earnings per share of -12 cents, beating the estimate of -14 cents. With 749.21K shares outstanding, the current market capitalization sits at 227.50M.
A.I. Advisor
published General Information

General Information

a manufacturer of novel dermatological therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
701 Lee Road
Phone
+1 484 324-7933
Employees
91
Web
https://www.aclaristx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVNDY13.040.01
+0.08%
Seven & I Holdings Co., Ltd.
OJIPF5.09N/A
N/A
Oji Holdings Corp
IVCAF11.02N/A
N/A
Investcorp AI Acquisition Corp.
EGHSF14.99-1.28
-7.86%
Enghouse Systems Ltd.
CMPD3.94-0.72
-15.45%
CompuMed, Inc.

ACRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with MYNZ. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then MYNZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+1.45%
MYNZ - ACRS
40%
Loosely correlated
-2.98%
IBRX - ACRS
34%
Loosely correlated
+0.42%
ITRM - ACRS
34%
Loosely correlated
+7.31%
ARCT - ACRS
31%
Poorly correlated
+6.50%
PDSB - ACRS
31%
Poorly correlated
-1.64%
More